The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study
Open accessAbstract
Objective The aim of this study was to describe the frequency, attribution, outcome and predictors of seizures in systemic lupus erythematosus (SLE). Methods The Systemic Lupus International Collaborating Clinics, or SLICC, performed a prospective inception cohort study. Demographic variables, global SLE disease activity (SLE Disease Activity Index 2000), cumulative organ damage (SLICC/American College of Rheumatology Damage Index (SDI)) and neuropsychiatric events were recorded at enrolment and annually. Lupus anticoagulant, anticardiolipin, anti-β2 glycoprotein-I, antiribosomal P and anti-NR2 glutamate receptor antibodies were measured at enrolment. Physician outcomes of seizures were recorded. Patient outcomes were derived from the SF-36 (36-Item Short Form Health Survey) mental component summary and physical component summary scores. Statistical analyses included Cox and linear regressions. Results The cohort was 89.4% female with a mean follow-up of 3.5±2.9 years. Of 1631 patients, 75 (4.6%) had ≥1 seizure, the majority around the time of SLE diagnosis. Multivariate analysis indicated a higher risk of seizures with African race/ethnicity (HR (CI): 1.97 (1.07 to 3.63); p=0.03) and lower education status (1.97 (1.21 to 3.19); p<0.01). Higher damage scores (without neuropsychiatric variables) were associated with an increased risk of subsequent seizures (SDI=1:3.93 (1.46 to 10.55); SDI=2 or 3:1.57 (0.32 to 7.65); SDI≥4:7.86 (0.89 to 69.06); p=0.03). There was an association with disease activity but not with autoantibodies. Seizures attributed to SLE frequently resolved (59/78 (76%)) in the absence of antiseizure drugs. There was no significant impact on the mental component summary or physical component summary scores. Antimalarial drugs in the absence of immunosuppressive agents were associated with reduced seizure risk (0.07 (0.01 to 0.66); p=0.03). Conclusion Seizures occurred close to SLE diagnosis, in patients with African race/ethnicity, lower educational status and cumulative organ damage. Most seizures resolved without a negative impact on health-related quality of life. Antimalarial drugs were associated with a protective effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shah, B. R., Laupacis, A., Hux, J. E., & Austin, P. C. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.016 · Cited by 493
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
Ruiz-Irastorza, G., Egurbide, M.-V., Pijoan, J.-I., Garmendia, M., Villar, I., Martinez-Berriotxoa, A., Erdozain, J.-G., & Aguirre, C. (2006) · Lupus · doi:10.1177/0961203306071872 · Cited by 411
Self-citation
Cited by
Systemic lupus erythematosus: Diagnosis and clinical management
Fava, A., & Petri, M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.001 · Cited by 754
Self-citationTreat-to-target in systemic lupus erythematosus: recommendations from an international task force
van Vollenhoven, R. F., Mosca, M., Bertsias, G., Isenberg, D., Kuhn, A., Lerstrøm, K., Aringer, M., Bootsma, H., Boumpas, D., Bruce, I. N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205139 · Cited by 740
Self-citationNeuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers
Jeltsch-David, H., & Muller, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.148 · Cited by 304
Epidemiology of systemic lupus erythematosus
Pons-Estel, G. J., Ugarte-Gil, M. F., & Alarcón, G. S. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1327352 · Cited by 259
Self-citationLewis, M. J., & Jawad, A. S. (2016) · Rheumatology · doi:10.1093/rheumatology/kew399 · Cited by 259
Metadata
- Authors
- Hanly, J. G., Urowitz, M. B., Su, L., Gordon, C., Bae, S.-C., Sanchez-Guerrero, J., Romero-Diaz, J., Wallace, D. J., Clarke, A. E., Ginzler, E., Merrill, J. T., Isenberg, D. A., Rahman, A., Petri, M., Fortin, P. R., Gladman, D., Bruce, I. N., Steinsson, K., Dooley, M., Khamashta, M. A., Alarcón, G. S., Fessler, B. J., Ramsey-Goldman, R., Manzi, S., Zoma, A. A., Sturfelt, G. K., Nived, O., Aranow, C., Mackay, M., Ramos-Casals, M., van Vollenhoven, R., Kalunian, K. C., Ruiz-Irastorza, G., Lim, S., Kamen, D. L., Peschken, C. A., Inanc, M., Theriault, C., Thompson, K., & Farewell, V.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 71
- Issue
- 9
- Pages
- 1502-1509
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2153921781
- Cited by
- 167
- References
- 2
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. https://app.cochat.ai/papers/10.1136/annrheumdis-2011-201089
- The paper
- Hanly, J. G., Urowitz, M. B., Su, L., Gordon, C., Bae, S.-C., Sanchez-Guerrero, J., Romero-Diaz, J., Wallace, D. J., Clarke, A. E., Ginzler, E., Merrill, J. T., Isenberg, D. A., Rahman, A., Petri, M., Fortin, P. R., Gladman, D., Bruce, I. N., Steinsson, K., Dooley, M., . . . Farewell, V. (2012). Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2011-201089
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.